feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouIndiaIndia
You
bookmarksYour BookmarkshashtagYour Topics
Trending
trending

ChatGPT faces worldwide outages

trending

Alphabet dominates with Gemini 3

trending

OpenAI improves ChatGPT after Gemini

trending

Chennai schools closed due to rain

trending

Rupee collapses beyond 90/USD

trending

Avengers Doomsday trailer breaks tradition

trending

Rupee hits record low

trending

Canara Bank raises ₹3,500 crore

trending

JioHotstar releases Dies Irae

Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2025 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / Perry's Fatal Ketamine Overdose: A Medical Mystery

Perry's Fatal Ketamine Overdose: A Medical Mystery

3 Dec

•

Summary

  • Ketamine, approved since 1970, treats depression and pain.
  • Perry died from ketamine's acute effects, losing consciousness and drowning.
  • Five individuals, including two doctors, pleaded guilty to drug charges.

Ketamine, a powerful dissociative anesthetic approved for medical use in 1970 and initially administered to soldiers in the Vietnam War, is now increasingly used for pain management and treating severe depression. The U.S. Food and Drug Administration expanded approval for a ketamine-derived nasal spray in January 2025 for treatment-resistant depression. Despite its therapeutic benefits, ketamine is also popular as an illicit party drug, known by street names like 'Vitamin K' and 'special K.'

The drug's use gained significant public attention following the death of actor Matthew Perry in October 2023. An autopsy revealed that Perry died from the acute effects of ketamine, which led to him losing consciousness and drowning in his hot tub. Toxicology reports indicated high levels of ketamine in his system, consistent with general anesthesia doses.

In the wake of Perry's overdose, five individuals, including two physicians, have pleaded guilty to federal drug charges for illegally procuring ketamine for the actor. One of these defendants, Dr. Salvador Plasencia, is scheduled for sentencing soon. Perry's death highlighted the risks associated with unsupervised at-home ketamine injections, a practice he reportedly resorted to after clinic doctors denied increased dosages.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
Ketamine is a dissociative anesthetic used for anesthesia, pain management, and treating severe depression, with a nasal spray approved in January 2025.
High levels of ketamine caused Perry to lose consciousness and drown in his hot tub, as indicated by autopsy and toxicology reports.
Five individuals, including two physicians, pleaded guilty to federal drug charges for illegally obtaining ketamine for Matthew Perry.

Read more news on

Healthside-arrow

You may also like

Holiday Hazards: Food, Jabs, and Fairy Lights!

18 hours ago • 7 reads

article image

FDA Memo: COVID Vaccine Linked to 10 Child Deaths

18 hours ago • 45 reads

FDA Pulls Back Controversial Talc Testing Rule

1 day ago • 21 reads

New Glasses Slow Kids' Nearsightedness

1 Dec • 21 reads

FDA Approves Sarepta's Elevidys with New Safety Warnings for DMD Treatment

17 Nov • 84 reads

article image